Calviri Scientists Find New Class of Biomarkers for Predicting Treatment Response in Cancer Patients
Newly observed anti-FSP antibodies also found to predict immune-related adverse events PHOENIX, May 23, 2023 /PRNewswire/ — Scientists studying immune checkpoint inhibitor (ICI) therapies in advanced lung cancer patients have found that a new class of blood-based biomarkers— anti-frameshift peptide antibodies, or anti-FSP antibodies— could be developed into improved or orthogonal tests for predicting tumor … Read more